Intangibles and the market value of Biopharmaceutical startups

Research output: Contribution to journalArticle

Abstract

This paper investigates the relationship between various measures of intangible capital and the market valuation of young biopharmaceutical firms. We employ a non-linear model to measure the impact of R&D, patents, alliances, organizational capital, and mergers on the value of 349 newly-incorporated firms between 1980 and 2006. We find that, with the exception of mergers, our measures of intangible capital have positive and significant effects on market values; the impact of R&D declines as firms mature; and the omission of either alliances or organizational capital leads to a significant overstatement of the influence of R&D.
Original languageEnglish
JournalThe Journal of Business Inquiry
Volume18
Issue number2
Publication statusPublished - 2018

Fingerprint

Start-ups
Biopharmaceuticals
Market value
Intangibles
Mergers
Organizational capital
Alliances
Intangible capital
Market valuation
Patents

Cite this

@article{489829a0a8c94406a97c63ecf0fda6c9,
title = "Intangibles and the market value of Biopharmaceutical startups",
abstract = "This paper investigates the relationship between various measures of intangible capital and the market valuation of young biopharmaceutical firms. We employ a non-linear model to measure the impact of R&D, patents, alliances, organizational capital, and mergers on the value of 349 newly-incorporated firms between 1980 and 2006. We find that, with the exception of mergers, our measures of intangible capital have positive and significant effects on market values; the impact of R&D declines as firms mature; and the omission of either alliances or organizational capital leads to a significant overstatement of the influence of R&D.",
author = "{Morales Valera}, {Rosa Mar{\'i}a} and Fatos Radoniqi",
year = "2018",
language = "English",
volume = "18",
journal = "The Journal of Business Inquiry",
number = "2",

}

Intangibles and the market value of Biopharmaceutical startups. / Morales Valera, Rosa María; Radoniqi, Fatos.

In: The Journal of Business Inquiry, Vol. 18, No. 2, 2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Intangibles and the market value of Biopharmaceutical startups

AU - Morales Valera, Rosa María

AU - Radoniqi, Fatos

PY - 2018

Y1 - 2018

N2 - This paper investigates the relationship between various measures of intangible capital and the market valuation of young biopharmaceutical firms. We employ a non-linear model to measure the impact of R&D, patents, alliances, organizational capital, and mergers on the value of 349 newly-incorporated firms between 1980 and 2006. We find that, with the exception of mergers, our measures of intangible capital have positive and significant effects on market values; the impact of R&D declines as firms mature; and the omission of either alliances or organizational capital leads to a significant overstatement of the influence of R&D.

AB - This paper investigates the relationship between various measures of intangible capital and the market valuation of young biopharmaceutical firms. We employ a non-linear model to measure the impact of R&D, patents, alliances, organizational capital, and mergers on the value of 349 newly-incorporated firms between 1980 and 2006. We find that, with the exception of mergers, our measures of intangible capital have positive and significant effects on market values; the impact of R&D declines as firms mature; and the omission of either alliances or organizational capital leads to a significant overstatement of the influence of R&D.

UR - http://journals.uvu.edu/index.php/jbi/article/view/116

M3 - Article

VL - 18

JO - The Journal of Business Inquiry

JF - The Journal of Business Inquiry

IS - 2

ER -